252 related articles for article (PubMed ID: 31196683)
1. Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
Nordin JD; Vazquez-Benitez G; Olsen A; Kuckler LC; Gao AY; Kharbanda EO
Vaccine; 2019 Jul; 37(30):4055-4060. PubMed ID: 31196683
[TBL] [Abstract][Full Text] [Related]
2. Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
Ray GT; Lewis N; Goddard K; Ross P; Duffy J; DeStefano F; Baxter R; Klein NP
Vaccine; 2017 May; 35(20):2668-2675. PubMed ID: 28404355
[TBL] [Abstract][Full Text] [Related]
3. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.
Caspard H; Steffey A; Mallory RM; Ambrose CS
BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581
[TBL] [Abstract][Full Text] [Related]
5. Live versus attenuated influenza vaccine uptake and post-vaccination influenza-like illness outcomes in HIV-infected US Air Force members.
Menegay JL; Xu X; Sunil TS; Okulicz JF
J Clin Virol; 2017 Oct; 95():72-75. PubMed ID: 28889083
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
[TBL] [Abstract][Full Text] [Related]
7. 2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
Poehling KA; Caspard H; Peters TR; Belongia EA; Congeni B; Gaglani M; Griffin MR; Irving SA; Kavathekar PK; McLean HQ; Naleway AL; Ryan K; Talbot HK; Ambrose CS
Clin Infect Dis; 2018 Feb; 66(5):665-672. PubMed ID: 29029064
[TBL] [Abstract][Full Text] [Related]
8. Live attenuated influenza vaccine use and safety in children and adults with asthma.
Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF;
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584
[TBL] [Abstract][Full Text] [Related]
9. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
[TBL] [Abstract][Full Text] [Related]
10. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
[TBL] [Abstract][Full Text] [Related]
11. Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial.
Loeb M; Russell ML; Manning V; Fonseca K; Earn DJ; Horsman G; Chokani K; Vooght M; Babiuk L; Schwartz L; Neupane B; Singh P; Walter SD; Pullenayegum E
Ann Intern Med; 2016 Nov; 165(9):617-624. PubMed ID: 27538259
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended.
Fogel B; Hicks S
Vaccine; 2017 Sep; 35(39):5278-5282. PubMed ID: 28760609
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
Kahn KE; Santibanez TA; Zhai Y; Singleton JA
Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
[TBL] [Abstract][Full Text] [Related]
16. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.
Gilbert PB; Fong Y; Juraska M; Carpp LN; Monto AS; Martin ET; Petrie JG
BMC Infect Dis; 2019 May; 19(1):453. PubMed ID: 31117986
[TBL] [Abstract][Full Text] [Related]
17. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
Krishnan A; Dar L; Saha S; Narayan VV; Kumar R; Kumar R; Amarchand R; Dhakad S; Chokker R; Choudekar A; Gopal G; Choudhary A; Potdar V; Chadha M; Lafond KE; Lindstrom S; Widdowson MA; Jain S
PLoS Med; 2021 Apr; 18(4):e1003609. PubMed ID: 33914729
[TBL] [Abstract][Full Text] [Related]
19. Do parents prefer inactivated or live attenuated influenza vaccine for their children?
Santibanez TA; Kahn KE; Bridges CB
Vaccine; 2018 Nov; 36(48):7300-7305. PubMed ID: 30340880
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
